Market Size of Manual Resuscitator Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.40 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Manual Resuscitator Market Analysis
The Manual Resuscitator Market is expected to register a CAGR of 5.4% during the forecast period.
COVID-19 appears to have had a complex impact on patients with respiratory diseases during the pandemic. For instance, according to the study published in the National Library of Medicine in April 2021, cheaper alternatives for mechanical ventilation, mainly automated artificial manual-breathing units (AMBU) bags, had piqued the interest of clinicians, researchers, and policymakers due to their rapid production, low cost of deployment, and easy accessibility to a larger portion of the global population. The boom of low-cost resuscitation technologies was built all around the world to combat the ongoing COVID-19 pandemic. Thus, the COVID-19 pandemic positively impacted the market studied. The market studied is expected to follow the same trend over the forecast period as the burden of respiratory diseases is expected to increase.
The increasing prevalence rate of chronic obstructive pulmonary disease (COPD) and development related to resuscitators is expected to boost the manual resuscitator market growth. Chronic obstructive pulmonary disease (COPD) is a prevalent, curable chronic lung illness that affects both men and women worldwide. As per the European Respiratory Society's (ERS) research study published in January 2021, it is estimated that 36,580,965 Europeans were affected with COPD in 2020, with the number expected to rise to 49,453,852 by 2050. Thus, the growing prevalence of COPD worldwide increases the demand for resuscitators, thereby boosting market growth.
Likewise, the increasing geriatric population around the world is expected to boost the market's growth as this population is more prone to respiratory diseases. According to the World Population Prospects 2022, the population of the world is projected to reach 8 billion people in November 2022. According to the United Nations' most recent forecasts, the global population might reach 8.5 billion in 2030, 9.7 billion in 2050, and 10.4 billion in 2100. As a result, the expanding geriatric population is likely to push the market's growth during the forecast period, because COPD is a widely prevalent condition found in people over the age of 65, and COPD in older adults can cause major health difficulties if not treated correctly.
Moreover, technological advancement in the products and launches is likely to support the growth of the market. For instance, in July 2022, Mercury Medical's manual resuscitation line recently achieved MDR CE Mark Certification. This certification ensures the quality system is by Regulation (EU) 2017/745 allowing for CPR product line sales in the European market. Thus, all factors above are expected to boost market growth over the forecast period.
However, the presence of alternatives in the market is expected to restrain the market growth.
